Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Nuo Therapeutics Inc's Business Segments
Nuo Therapeutics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2025
Reportable Segments
1
Largest Segment
Single Reportable Segment
Total Revenue
$ 1
Regions Reported
-
Revenue Share by Reportable Segment - Q2 FY2025
- Single Reportable Segment100%
Revenue by Reportable Segment - Q2 FY2025
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Single Reportable Segment | $ 1 | 100% |
Revenue by Product & Service Category - Q2 FY2025
- Product89.3%
- License10.7%
Revenue by Product & Service Category - Q2 FY2025
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 1 | 89.3% |
| License | $ 0 | 10.7% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue by Product & Service Category -
- License7%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| License | $ 0 | 7% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Nuo Therapeutics Inc
Nuo Therapeutics Inc is a biotechnology company based in Germantown, Maryland. The company specializes in the development and commercialization of innovative regenerative therapies for chronic wound care and other advanced wound healing applications.
Nuo Therapeutics Inc focuses on advancing its proprietary platform technology, known as Aurix, which harnesses the body's natural healing processes to promote tissue repair and regeneration. Aurix is a biologically active plasma-derived composition that contains a rich mixture of growth factors, cytokines, and other bioactive molecules. It is derived from the patient's own blood and applied topically to the wound site, stimulating healing by accelerating cell proliferation, angiogenesis, and extracellular matrix formation.
The company primarily targets conditions such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical wounds. These chronic wounds often have a significant impact on patients' quality of life and pose a considerable economic burden on the healthcare system. Nuo Therapeutics Inc's regenerative therapies aim to address this unmet medical need by promoting faster healing, reducing infection risks, and improving patient outcomes.
Nuo Therapeutics Inc also recognizes the importance of evidence-based medicine and conducts rigorous clinical trials to validate the safety and efficacy of its products. The company collaborates with leading academic institutions and medical professionals to conduct these studies, gathering robust data that supports its therapies' effectiveness.
Furthermore, Nuo Therapeutics Inc serves as a comprehensive wound care solutions provider, offering a holistic package that includes training, support, and education for healthcare professionals. The company aims to ensure proper utilization of its therapies and optimize patient care by offering tailored wound care protocols, best practices, and ongoing clinical support.
In terms of market presence, Nuo Therapeutics Inc operates in the United States and strives to expand its global reach. The company's business model revolves around partnerships with healthcare providers, wound care centers, hospitals, and other relevant stakeholders. Through these collaborations, Nuo Therapeutics Inc aims to establish a strong network and accelerate the adoption of its regenerative therapies in diverse healthcare settings.
Overall, Nuo Therapeutics Inc is dedicated to transforming the field of chronic wound care and advancing the standard of care for patients suffering from debilitating wounds. By leveraging its cutting-edge technology, clinical expertise, and strategic collaborations, the company aims to make a significant impact on the lives of those affected by chronic wounds, reducing the burden on patients and healthcare systems alike.
Nuo Therapeutics Inc focuses on advancing its proprietary platform technology, known as Aurix, which harnesses the body's natural healing processes to promote tissue repair and regeneration. Aurix is a biologically active plasma-derived composition that contains a rich mixture of growth factors, cytokines, and other bioactive molecules. It is derived from the patient's own blood and applied topically to the wound site, stimulating healing by accelerating cell proliferation, angiogenesis, and extracellular matrix formation.
The company primarily targets conditions such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical wounds. These chronic wounds often have a significant impact on patients' quality of life and pose a considerable economic burden on the healthcare system. Nuo Therapeutics Inc's regenerative therapies aim to address this unmet medical need by promoting faster healing, reducing infection risks, and improving patient outcomes.
Nuo Therapeutics Inc also recognizes the importance of evidence-based medicine and conducts rigorous clinical trials to validate the safety and efficacy of its products. The company collaborates with leading academic institutions and medical professionals to conduct these studies, gathering robust data that supports its therapies' effectiveness.
Furthermore, Nuo Therapeutics Inc serves as a comprehensive wound care solutions provider, offering a holistic package that includes training, support, and education for healthcare professionals. The company aims to ensure proper utilization of its therapies and optimize patient care by offering tailored wound care protocols, best practices, and ongoing clinical support.
In terms of market presence, Nuo Therapeutics Inc operates in the United States and strives to expand its global reach. The company's business model revolves around partnerships with healthcare providers, wound care centers, hospitals, and other relevant stakeholders. Through these collaborations, Nuo Therapeutics Inc aims to establish a strong network and accelerate the adoption of its regenerative therapies in diverse healthcare settings.
Overall, Nuo Therapeutics Inc is dedicated to transforming the field of chronic wound care and advancing the standard of care for patients suffering from debilitating wounds. By leveraging its cutting-edge technology, clinical expertise, and strategic collaborations, the company aims to make a significant impact on the lives of those affected by chronic wounds, reducing the burden on patients and healthcare systems alike.
Nuo Therapeutics Inc. primarily focuses on the development of innovative therapies aimed at addressing a range of chronic and acute wound care needs. The company is especially known for its contributions to the field of regenerative medicine and therapeutic devices. Below is an extensive description of the segments, products, and services Nuo Therapeutics offers:
Segments
1. Regenerative Medicine:
Nuo Therapeutics operates in the regenerative medicine segment focusing on promoting healing in chronic wounds. This segment emphasizes the use of biological therapies to stimulate the body’s natural healing processes.
2. Wound Care:
This segment encompasses both acute and chronic wound management, targeting various conditions such as diabetic ulcers, venous leg ulcers, and pressure ulcers. The products developed aim to enhance tissue healing and reduce the time to recovery.
3. Therapeutic Devices:
The company develops and commercializes therapeutic devices that provide innovative solutions to clinicians and healthcare providers. These devices may range from advanced dressing systems to specialized instruments designed for specific treatments.
Products
1. Aurix™:
Nuo Therapeutics’ flagship product, Aurix™, is a tissue autograft designed for wound care management. It is derived from the patients own blood, processed to extract growth factors, and applied directly to the wound site. This product aids in accelerating the healing process by utilizing the bodys regenerative capabilities.
2. Hydrogel Dressings:
These are advanced wound dressings designed to maintain a moist wound environment, promote healing, and minimize pain. The hydrogel formulations are easy to apply and provide an effective barrier against infection.
3. Negative Pressure Wound Therapy (NPWT):
Nuo Therapeutics includes devices in its portfolio that leverage negative pressure wound therapy, which helps in promoting angiogenesis and reducing edema, thereby facilitating faster healing in complex wounds.
4. Biologic Skin Substitutes:
The company may offer various biologic skin substitutes designed to act as temporary skin replacements in the treatment of severe wounds. These products aim to provide a scaffold for new tissue growth while protecting the wound from external contaminants.
Services
1. Patient Monitoring and Support:
Nuo Therapeutics provides a suite of services aimed at patient support during the wound treatment process. This may include guidance on wound care best practices and monitoring the effectiveness of the treatment.
2. Clinical Education and Training:
The company invests in educating healthcare professionals about the most effective use of its products and technologies. Training programs may be tailored for different healthcare settings, ensuring clinicians are well-equipped to utilize the therapies effectively.
3. Customized Treatment Plans:
Nuo Therapeutics offers services that help clinicians in forming personalized treatment plans based on individual patient needs. This includes assessing the particular characteristics of the wound and determining the most appropriate therapeutic approach.
4. Consultative Services:
The company may offer consultative services to healthcare providers, helping them navigate complex cases and optimize wound care management protocols.
5. Research and Development Collaborations:
Nuo Therapeutics might engage in partnerships with other researchers or institutions to advance wound healing sciences, developing new treatment methodologies and technologies.
Future Directions
Nuo Therapeutics is likely to continue expanding its product offerings within the regenerative medicine and wound care sectors, potentially incorporating advanced technologies such as bioengineering, 3D printing for tissue scaffolding, or novel drug delivery systems. The ongoing trend in personalized medicine may also lead to developments that focus on tailoring treatments specifically for individual patient profiles.
This comprehensive view of Nuo Therapeutics Inc.s segments, products, and services highlights the companys commitment to advancing wound care and regenerative medicine, serving the critical needs of patients and healthcare providers alike.
Segments
1. Regenerative Medicine:
Nuo Therapeutics operates in the regenerative medicine segment focusing on promoting healing in chronic wounds. This segment emphasizes the use of biological therapies to stimulate the body’s natural healing processes.
2. Wound Care:
This segment encompasses both acute and chronic wound management, targeting various conditions such as diabetic ulcers, venous leg ulcers, and pressure ulcers. The products developed aim to enhance tissue healing and reduce the time to recovery.
3. Therapeutic Devices:
The company develops and commercializes therapeutic devices that provide innovative solutions to clinicians and healthcare providers. These devices may range from advanced dressing systems to specialized instruments designed for specific treatments.
Products
1. Aurix™:
Nuo Therapeutics’ flagship product, Aurix™, is a tissue autograft designed for wound care management. It is derived from the patients own blood, processed to extract growth factors, and applied directly to the wound site. This product aids in accelerating the healing process by utilizing the bodys regenerative capabilities.
2. Hydrogel Dressings:
These are advanced wound dressings designed to maintain a moist wound environment, promote healing, and minimize pain. The hydrogel formulations are easy to apply and provide an effective barrier against infection.
3. Negative Pressure Wound Therapy (NPWT):
Nuo Therapeutics includes devices in its portfolio that leverage negative pressure wound therapy, which helps in promoting angiogenesis and reducing edema, thereby facilitating faster healing in complex wounds.
4. Biologic Skin Substitutes:
The company may offer various biologic skin substitutes designed to act as temporary skin replacements in the treatment of severe wounds. These products aim to provide a scaffold for new tissue growth while protecting the wound from external contaminants.
Services
1. Patient Monitoring and Support:
Nuo Therapeutics provides a suite of services aimed at patient support during the wound treatment process. This may include guidance on wound care best practices and monitoring the effectiveness of the treatment.
2. Clinical Education and Training:
The company invests in educating healthcare professionals about the most effective use of its products and technologies. Training programs may be tailored for different healthcare settings, ensuring clinicians are well-equipped to utilize the therapies effectively.
3. Customized Treatment Plans:
Nuo Therapeutics offers services that help clinicians in forming personalized treatment plans based on individual patient needs. This includes assessing the particular characteristics of the wound and determining the most appropriate therapeutic approach.
4. Consultative Services:
The company may offer consultative services to healthcare providers, helping them navigate complex cases and optimize wound care management protocols.
5. Research and Development Collaborations:
Nuo Therapeutics might engage in partnerships with other researchers or institutions to advance wound healing sciences, developing new treatment methodologies and technologies.
Future Directions
Nuo Therapeutics is likely to continue expanding its product offerings within the regenerative medicine and wound care sectors, potentially incorporating advanced technologies such as bioengineering, 3D printing for tissue scaffolding, or novel drug delivery systems. The ongoing trend in personalized medicine may also lead to developments that focus on tailoring treatments specifically for individual patient profiles.
This comprehensive view of Nuo Therapeutics Inc.s segments, products, and services highlights the companys commitment to advancing wound care and regenerative medicine, serving the critical needs of patients and healthcare providers alike.